Seattle Genetics, Inc. is an emerging multi-product, global biotechnology company that develops and commercializes transformative therapies targeting cancer to make a meaningful difference in people’s ...
* Seattle Genetics - signed definitive agreements to purchase Bristol-Myers Squibb's pharmaceutical manufacturing facility in Bothell, Washington * Seattle Genetics - intends to offer employment to ...
BOTHELL, Wash.--(BUSINESS WIRE)--Seattle Genetics, Inc. (NASDAQ:SGEN) announced today that management will present at the Morgan Stanley Global Healthcare Conference on Tuesday, September 12, 2017 at ...
BOTHELL, Wash. (AP) - Biotechnology company Seattle Genetics Inc. said Thursday it will receive an $8 million fee from Pfizer Inc. for rights to use its cancer-fighting antibody-drug conjugate ...
<a href="http://profiles.portfolio.com/company/us/wa/bothell/seattle_genetics_inc_/1087062/"><strong>Seattle Genetics Inc.</strong></a> has expanded an existing deal ...
<a href="http://www.bizjournals.com/profiles/company/us/wa/bothell/seattle_genetics_inc/1087062/">Seattle Genetics Inc.</a> said the NASDAQ stock exchange has halted ...
BOTHELL, Wash. (AP) — BOTHELL, Wash. (AP) — Seattle Genetics Inc. (SGEN) on Wednesday reported a loss of $215.8 million in its third quarter. The Bothell, Washington-based company said it had a loss ...
BOTHELL, Wash. (AP) — BOTHELL, Wash. (AP) — Seattle Genetics Inc. (SGEN) on Wednesday reported a loss of $211.5 million in its second quarter. On a per-share basis, the Bothell, Washington-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback